Blossomhill Therapeutics Inc <BLSM.O>: JP Morgan raises target price to $30 from $28
BLSM•Related News
CNN, MS Now, Politico sue Donald Trump over White House ban, court records show
WBD•
Tempus and Recursion extend existing data license agreement and enter new license agreement for Recursion’s RNA foundation model
RXRX•
Celanese Corp Announces Global Price Increases For Acetyl Products
CE•
Turning Point Brands Appoints David E. Glazek As CEO Effective October 1, 2026
TPB•
Nasdaq Trade Halt <VEEE.O> Volatility Trading Pause at 09:32 AM
VEEE•